Argenx
ARGX
#479
Rank
A$72.39 B
Marketcap
A$1,170
Share price
-1.92%
Change (1 day)
19.02%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: A$72.39 Billion

As of February 2026 Argenx has a market cap of A$72.39 Billion. This makes Argenx the world's 479th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$72.39 B-7.85%
2025A$78.55 B30.47%
2024A$60.21 B81.78%
2023A$33.12 B7.55%
2022A$30.79 B21.41%
2021A$25.36 B39.11%
2020A$18.23 B85.61%
2019A$9.82 B97.4%
2018A$4.97 B93.8%
2017A$2.56 B
2014A$0.17 B

End of Day market cap according to different sources

On Feb 22nd, 2026 the market cap of Argenx was reported to be:

A$72.74 Billion
by Nasdaq info icon info icon
A$73.81 Billion
by CompaniesMarketCap info icon info icon